We are live on ! Find out more
NITE

Nightstar Therapeutics plc American Depositary Shares
NITE

Delisted

NITE was delisted on the 6th of June, 2019.

29 hedge funds and large institutions have $127M invested in Nightstar Therapeutics plc American Depositary Shares in 2018 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 5 increasing their positions, 13 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

19% less funds holding

Funds holding: 3629 (-7)

42% less capital invested

Capital invested by funds: $218M → $127M (-$91.7M)

47% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 15

62% less repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 13

Holders
29
Holders Change
-7
Holders Change %
-19.44%
% of All Funds
0.65%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
8
Increased
5
Reduced
13
Closed
15
Calls
Puts
Net Calls
Net Calls Change

NITE Hedge Fund Activity: Q4 2018 in Review

29 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in Nightstar Therapeutics plc American Depositary Shares (NITE) for Q4 2018, worth a combined $127M — down 42% from $218M a quarter earlier.

Sellers outnumbered buyers: 15 funds closed out of NITE and 8 opened new positions — a net loss of 7 holders — while 13 trimmed existing stakes and 5 added.

The largest buyer was Woodford Investment Management, adding an estimated $16.5M. The largest seller was Deerfield Management, exiting entirely with an estimated $10.2M sold.

  • 29 institutional investors held Nightstar Therapeutics plc American Depositary Shares (NITE) as of Q4 2018, down from 36 in Q3 2018.
  • Funds reported $127M of Nightstar Therapeutics plc American Depositary Shares stock for Q4 2018, down 42% quarter-over-quarter.
  • 8 funds opened new Nightstar Therapeutics plc American Depositary Shares positions in Q4 2018 and 15 closed out, a net change of -7 holders.
  • The largest Nightstar Therapeutics plc American Depositary Shares buyer in Q4 2018 was Woodford Investment Management, an estimated $16.5M added.
  • The largest Nightstar Therapeutics plc American Depositary Shares seller in Q4 2018 was Deerfield Management, an estimated $10.2M sold.

Based on aggregated 13F filings for Q4 2018.